Last reviewed · How we verify
NCT04277416
Survivorship and Effectiveness of the Ortho Development® Entrada™ Hip System for Total Hip Arthroplasty
trial testing Total Hip Arthroplasty in Total Hip Replacement in 250 participants. Enrolling by invitation.
31 December 2031
Quick facts
| Lead sponsor | Ortho Development Corporation |
|---|---|
| Status | ENROLLING BY INVITATION |
| Study type | OBSERVATIONAL |
| Enrollment | 250 |
| Start date | 28 February 2020 |
| Primary completion | 31 December 2031 |
| Estimated completion | 31 December 2032 |
| Sites | 1 location across United States |
Drugs / interventions tested
- Total Hip Arthroplasty
Conditions studied
- Total Hip Replacement — all drugs for Total Hip Replacement →
- Total Hip Arthroplasty — all drugs for Total Hip Arthroplasty →
Sponsor
Ortho Development Corporation
Who can join
Adults 18 to 80, any sex, with Total Hip Replacement or Total Hip Arthroplasty. Patients with the condition only — healthy volunteers not accepted.
Sponsor's own description
To evaluate Implant survival based on removal or intended removal of any component of the Entrada™ Hip System at five years of follow-up.
Publications & conference data
No peer-reviewed publications indexed yet for this trial.
Verify or expand the search:
- PubMed search for NCT04277416
- Europe PMC full search
- ASCO Meeting Library
- ESMO Meeting Library
- bioRxiv preprints
- medRxiv preprints
- Google Scholar
Related trials
Other trials of Total Hip Arthroplasty
Trials testing the same drug.
- NCT06640764 — Multicentre SMS Study - FR · recruiting
- NCT06499038 — The Ace Avanteon Study - A Randomized Controled Trial · NA · recruiting
- NCT06342843 — Direct Superior Approach Versus PosteroLateral Approach in Total Hip Arthroplasty (SPLAsH) · NA · recruiting
- NCT07409909 — Total Hip Arthroplasty Versus Bipolar Hemiarthroplasty for Treatment of Intracapsular Displaced Fracture Neck Femur in E · NA · completed
- NCT05357664 — PINNACLE® DM RSA Study · NA · terminated
Other recruiting trials for Total Hip Replacement
Currently open trials in the same condition.
- NCT07226700 — Suzetrigine in Total Hip Arthroplasty · Phase 3 · recruiting
- NCT07120191 — An Open Label Data Collection Study of My Connect Post-Op, a Post-Operative Communication Tool · recruiting
- NCT06878014 — Comparing the Safety and Effectiveness of Different Doses of Morphine Administered in Spinal Anethesia for Pain Relief A · Phase 4 · recruiting
- NCT06238960 — Effectiveness of Telerehabilitation in Continuity With Outpatient Physiotherapy After Total Hip Replacement. · NA · recruiting
- NCT06628336 — Post-Market Observational Study of the HARMONY® Evolution Implants and Instruments · recruiting
Other Ortho Development Corporation trials
Trials by the same sponsor.
- NCT03986918 — Survivorship and Patient Outcomes of Primary Total Hip Arthroplasty With the Ovation Hip System · unknown
Verify against primary sources
- ClinicalTrials.gov — authoritative US registry record
- WHO ICTRP — international registry index
- EU Clinical Trials Register
- Sponsor press releases (Google)
- Trial protocol + status: ClinicalTrials.gov NCT04277416 (US National Library of Medicine, public domain)
- Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
- Sponsor: as reported to ClinicalTrials.gov by Ortho Development Corporation
- Last refreshed: 13 October 2022
Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT04277416.
Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing